MaxorPlus selects Hy-Vee’s Amber Pharmacy for dispensing to transplant patientsMaxorPlus clients can choose Amber Pharmacy’s service model for members with organ transplant medication needs. AmerisourceBergen to support Deciphera's QinlockAmerisourceBergen is providing a unified commercialization approach for Qinlock, a treatment for patients with a rare form of cancer. Akorn files for bankruptcy Akorn said it will continue to operate as usual throughout the duration of the Chapter 11 and sale process, including meeting its contractual obligations and making payments to vendors. AllianceRx Walgreens Prime to distribute Lundbeck's Vyepti AllianceRx Walgreens Prime will distribute Lundbeck's Vyepti, an intravenous preventive migraine treatment. Survey: Specialty pharmacists report administrative delays to treatment A Surescripts survey finds that nearly two-thirds of specialty pharmacists report spending more than 15 minutes on the phone to fill one prescription. IQVIA report: Global medicine spending to top $1.1T by 2024 IQVIA reports that global use of medicine has increased at a 3% compound annual growth rate since 2014, slowing from a 4% rate from 2009–2014. Hikma, Glenmark ink licensing agreement for Ryaltris Glenmark and Hikma will commercialize a fixed-dose combination nasal spray for seasonal allergic rhinitis. United Therapeutics, DEKA get FDA OK for subcutaneous delivery system for Remodulin The Remunity system to treat pulmonary arterial hypertension is expected to be available by July for specialty pharmacies. Grifols launches Xembify Grifol’s Xembify is the first 20% subcutaneous immunoglobulin for primary immunodeficiency treatment. Walgreens earns enterprise-wide URAC Specialty Pharmacy accreditation Walgreens has earned the first enterprise-wide URAC Specialty Pharmacy accreditation for its network of more than 300 community specialty pharmacies. First Previous 15 16 17 18 19 Next Last